Vivek Subbiah: An Honor to Deliver Two Keynote Lectures at the OncoNext Meeting - OncoDaily

Vivek Subbiah: An Honor to Deliver Two Keynote Lectures at the OncoNext Meeting / cancer, Fabio Franke, Juliana Beal, OncoDaily, Oncology, Roberto Pestana,

oncodaily.com

"Think Globally, Act Locally": Vivek Subbiah Emphasizes International Partnerships in Precision Medicine - OncoDaily

oncodaily.com

Vivek Subbiah: Tumor-Agnostic Therapies and the Need for Living Guidelines - OncoDaily

Vivek Subbiah: Tumor-Agnostic Therapies and the Need for Living Guidelines / ASCO, cancer, Jim Palma, OncoDaily, Oncology, Razelle Kurzrock, Thomas K. Oliver,

oncodaily.com

Vivek Subbiah: ARROW Study Final Results in RET-Positive Lung Cancer - OncoDaily

Vivek Subbiah: ARROW Study Final Results in RET-Positive Lung Cancer / 19th annual New York Lung Cancers Symposium, Aaron S. Mansfield, Amber Thomassen,

oncodaily.com

Vivek Subbiah: Honoring the Life, the Legacy, and the Light He Continues to Shine... - OncoDaily

Vivek Subbiah: Honoring the Life, the Legacy, and the Light He Continues to Shine... / cancer, Martin Luther King, OncoDaily, Oncology, Vivek Subbiah

oncodaily.com

Vivek Subbiah: Shared Vision for Accelerating Tissue-Agnostic Drug Development at Miami Precision Oncology Symposium - OncoDaily

Vivek Subbiah: Shared Vision for Accelerating Tissue-Agnostic Drug Development at Miami Precision Oncology Symposium / Baptist health, cancer, Manmeet

oncodaily.com

Vivek Subbiah: AI-Driven Screening Opens New Era in Drug Discovery - OncoDaily

Vivek Subbiah: AI-Driven Screening Opens New Era in Drug Discovery / Bowen Gao, cancer, Chuangye Yan, Haichuan Tan, Hongyi Cai, Jiaxin Tan, Jiekang Tian,

oncodaily.com

Vivek Subbiah: Rethinking Cancer of Unknown Primary in Precision Oncology Era - OncoDaily

Vivek Subbiah: Rethinking Cancer of Unknown Primary in Precision Oncology Era / cancer, F. Anthony Greco, Journal of Clinical Oncology, OncoDaily, Oncology,

oncodaily.com

Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025 - OncoDaily

Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025 / cancer, Great Debates,

oncodaily.com

Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It - OncoDaily

Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It / cancer, OncoDaily, Oncology, Vivek Subbiah

oncodaily.com

10 Papers Suggested by Vivek Subbiah - OncoDaily

10 Papers Suggested by Vivek Subbiah / Alessio Nencioni, Alexander G Bick, Ali J. Haidar, Ana Barac, Ana Guijarro, Andres Daniele, Angela Chen, Ashwin

oncodaily.com

Why cancer can come back years later — and how to stop it

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

nature.com

10 Must-Read Posts in GI Oncology This Week - OncoDaily

10 Must-Read Posts in GI Oncology This Week / cancer, cancer care, Cancer research, cancer treatment, clinical trials, Colorectal Cancer (CRC),

oncodaily.com

Science in 2026: the events to watch for in the coming year

The rise of AI scientists, missions to explore the moons of Earth and Mars and a massive ocean-floor drill are among the developments set to shape research in 2026.

nature.com

Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers - OncoDaily

Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers / cancer, cancer treatment, Headlines,

oncodaily.com

Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial - OncoDaily

Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial / Agnese Fabbri, Alberto Zambelli, Andrea Botticelli, Andrea DeCensi, Annamaria Pessino, Bruna

oncodaily.com

Vivek Subbiah: ONE of the Most Impactful Meetings in Rare Cancer Research - OncoDaily

Vivek Subbiah: ONE of the Most Impactful Meetings in Rare Cancer Research / cancer, OncoDaily, Oncology, Razelle Kurzrock, Target Cancer Foundation, Think

oncodaily.com

Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare Cancers | JCO Oncology Practice

ascopubs.org

Vivek Subbiah: ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology - OncoDaily

Vivek Subbiah: ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology / cancer, ESMO, ESMO 2025, OncoDaily, Oncology, Vivek Subbiah

oncodaily.com

Vivek Subbiah: Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions - OncoDaily

Vivek Subbiah: Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions / cancer, ESMO Annual Meeting, ESMO25, Maximilian Kloft,

oncodaily.com

Vivek Subbiah: Precision Oncology and Modernizing Evidence Standards - OncoDaily

Vivek Subbiah: Precision Oncology and Modernizing Evidence Standards / cancer, OncoDaily, Oncology, Razelle Kurzrock, Vivek Subbiah

oncodaily.com

Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin - OncoDaily

Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO Presidential Dinner, ESMO2025, ESMO25,

oncodaily.com

Vivek Subbiah: Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine - OncoDaily

Vivek Subbiah: Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25,

oncodaily.com

Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research - OncoDaily

Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research / American Society of Clinical Oncology, ASCO, cancer,

oncodaily.com